Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRN Immuron Ltd

交易中 07-24 14:45:47 EDT

2.55

+0.13

+5.37%

最高2.55	最低2.55	成交量182.00
今开2.55	昨收2.42	日振幅0.00%
总市值1,453万	流通市值1,202万	总股本570.00万
成交额461.97	换手率0.00%	流通股本471.42万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRN","market":"US","secType":"STK","nameCN":"Immuron Ltd","latestPrice":2.55,"timestamp":1721838230658,"preClose":2.42,"halted":0,"volume":182,"delay":0,"floatShares":4714200,"shares":5699958,"eps":-0.464567,"marketStatus":"交易中","marketStatusCode":2,"change":0.13,"latestTime":"07-24 14:45:47 EDT","open":2.55,"high":2.55,"low":2.55,"amount":461.9699084,"amplitude":0,"askPrice":2.55,"askSize":100,"bidPrice":2.31,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.464567,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721851200000},"adr":1,"adjPreClose":2.42,"adrRate":40,"preHourTrading":{"tag":"盘前","latestPrice":2.38,"preClose":2.42,"latestTime":"04:33 EDT","volume":2,"amount":4.76,"timestamp":1721810001025},"postHourTrading":{"tag":"盘后","latestPrice":2.42,"preClose":2.5797,"latestTime":"19:34 EDT","volume":943,"amount":2283.46,"timestamp":1721777663934},"volumeRatio":0.039659},"requestUrl":"/m/hq/s/IMRN/tweets","defaultTab":"tweets","newsList":[{"id":"2453888862","title":"Immuron Limited盘中异动 急速跳水6.19%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453888862","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453888862?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:32","pubTimestamp":1721827925,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日21时32分，Immuron Limited股票出现异动，股价大幅跳水6.19%。截至发稿，该股报2.42美元/股，成交量22股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.25%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242132059ee65246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242132059ee65246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2453919037","title":"Immuron Limited盘中异动 早盘股价大跌6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453919037","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453919037?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:34","pubTimestamp":1721741696,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时34分，Immuron Limited股票出现波动，股价快速下跌6.07%。截至发稿，该股报2.32美元/股，成交量163股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.31%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232134569681f57c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232134569681f57c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2453923793","title":"Immuron Limited盘中异动 股价大跌6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453923793","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453923793?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:50","pubTimestamp":1721656200,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时50分，Immuron Limited股票出现异动，股价快速下挫6.44%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.11%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722215000aefaca73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722215000aefaca73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2452164696","title":"Immuron Limited盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452164696","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452164696?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:49","pubTimestamp":1721231349,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时49分，Immuron Limited股票出现异动，股价快速下跌5.60%。截至发稿，该股报2.53美元/股，成交量1081股，换手率0.02%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为2.61%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234909aefa28b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234909aefa28b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2451799042","title":"Immuron Limited盘中异动 早盘快速上涨7.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451799042","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451799042?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:46","pubTimestamp":1721137566,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时46分，Immuron Limited股票出现波动，股价急速上涨7.18%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.58%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716214606aef9f4e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716214606aef9f4e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2451280756","title":"Immuron Limited盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451280756","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451280756?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:33","pubTimestamp":1721050438,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时33分，Immuron Limited股票出现异动，股价急速拉升5.26%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.18%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213358af9264da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213358af9264da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2450581707","title":"Immuron Limited盘中异动 临近午盘快速下跌6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450581707","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450581707?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:53","pubTimestamp":1720626782,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日23时53分，Immuron Limited股票出现波动，股价大幅跳水6.67%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.00%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102353029f2e128d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102353029f2e128d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4007","BK4139","VRPX"],"gpt_icon":0},{"id":"2450029858","title":"Immuron Limited股价拉升12.35% 市值涨166.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450029858","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450029858?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:37","pubTimestamp":1720535821,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时37分，Immuron Limited股票出现异动，股价急速拉升12.35%。截至发稿，该股报2.37美元/股，成交量114股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.95%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092237019597babf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092237019597babf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGVN","IMRN"],"gpt_icon":0},{"id":"2449102701","title":"Immuron Limited股价上涨11.69% 市值涨149.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449102701","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449102701?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:38","pubTimestamp":1720449480,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时38分，Immuron Limited股票出现波动，股价大幅上涨11.69%。截至发稿，该股报2.25美元/股，成交量378股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.94%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082238009590f28b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082238009590f28b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","VRPX","IMRN"],"gpt_icon":0},{"id":"2449883293","title":"Immuron Limited盘中异动 早盘大幅拉升8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449883293","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449883293?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:47","pubTimestamp":1720187274,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时47分，Immuron Limited股票出现波动，股价急速上涨8.11%。截至发稿，该股报2.18美元/股，成交量277股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.24%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705214754aef82d82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705214754aef82d82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2448485346","title":"Immuron Limited盘中异动 早盘股价大跌7.45%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448485346","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448485346?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:49","pubTimestamp":1720014558,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时49分，Immuron Limited股票出现波动，股价快速跳水7.45%。截至发稿，该股报2.00美元/股，成交量4237股，换手率0.07%，振幅5.01%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.25%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703214918af906610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703214918af906610&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2448945444","title":"Immuron Limited股价重挫13.64% 市值跌11.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448945444","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448945444?lang=zh_cn&edition=full","pubTime":"2024-07-02 01:44","pubTimestamp":1719855868,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日01时44分，Immuron Limited股票出现异动，股价急速下挫13.64%。截至发稿，该股报2.09美元/股，成交量222股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.27%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702014429aef770f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702014429aef770f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2445723110","title":"Immuron Limited盘中异动 早盘股价大涨5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445723110","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445723110?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:42","pubTimestamp":1719236522,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时42分，Immuron Limited股票出现波动，股价大幅拉升5.19%。截至发稿，该股报2.23美元/股，成交量10股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.84%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421420295d2be25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421420295d2be25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2435511849","title":"Immuron Limited盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435511849","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435511849?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:48","pubTimestamp":1715694534,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时48分，Immuron Limited股票出现异动，股价急速下跌5.31%。截至发稿，该股报2.26美元/股，成交量914股，换手率0.02%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.10%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421485479279f1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421485479279f1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2434601419","title":"Immuron Limited盘中异动 临近午盘股价大跌5.70%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434601419","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434601419?lang=zh_cn&edition=full","pubTime":"2024-05-09 23:37","pubTimestamp":1715269064,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日23时37分，Immuron Limited股票出现异动，股价大幅跳水5.70%。截至发稿，该股报2.36美元/股，成交量113股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.46%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092337447926cb50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092337447926cb50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2432508953","title":"Immuron Limited盘中异动 大幅拉升7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432508953","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432508953?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:03","pubTimestamp":1714572197,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时03分，Immuron Limited股票出现波动，股价快速拉升7.68%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.19%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012203177a57dc61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012203177a57dc61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2432775983","title":"Immuron Limited盘中异动 快速下跌6.61%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432775983","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432775983?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:16","pubTimestamp":1714493782,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日00时16分，Immuron Limited股票出现异动，股价快速下挫6.61%。截至发稿，该股报2.36美元/股，成交量2095股，换手率0.04%，振幅3.08%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.07%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050100162279258bcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050100162279258bcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2431862725","title":"Immuron Limited盘中异动 早盘急速下跌7.19%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431862725","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431862725?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:01","pubTimestamp":1714399269,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时01分，Immuron Limited股票出现异动，股价大幅下跌7.19%。截至发稿，该股报2.45美元/股，成交量1759股，换手率0.03%，振幅0.38%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.03%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292201097a572c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292201097a572c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"gpt_icon":0},{"id":"2430201557","title":"Immuron Limited盘中异动 早盘快速上涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430201557","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430201557?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:08","pubTimestamp":1714144081,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日23时08分，Immuron Limited股票出现异动，股价大幅拉升6.08%。截至发稿，该股报2.58美元/股，成交量155股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.21%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262308018b57bd72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262308018b57bd72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0},{"id":"2429146797","title":"Immuron Limited盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429146797","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429146797?lang=zh_cn&edition=full","pubTime":"2024-04-24 02:24","pubTimestamp":1713896645,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日02时24分，Immuron Limited股票出现波动，股价快速下跌5.44%。截至发稿，该股报2.46美元/股，成交量1411股，换手率0.02%，振幅3.77%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.71%。Immuron Limited公司简介：Immuron Ltd 是一家临床阶段的生物制药公司，专注于一类新型免疫调节剂多克隆抗体的开发和商业化，以治疗肝脏疾病、传染病和其他免疫介导的疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240224067922b791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240224067922b791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuron.com","stockEarnings":[{"period":"1week","weight":-0.0374},{"period":"1month","weight":0.2168},{"period":"3month","weight":0.036},{"period":"6month","weight":0.3944},{"period":"1year","weight":0.2815},{"period":"ytd","weight":0.3758}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.017},{"period":"3month","weight":0.0957},{"period":"6month","weight":0.1347},{"period":"1year","weight":0.2192},{"period":"ytd","weight":0.1651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司，拥有一个专利技术平台，专注于开发和商业化一类新型的特异性靶向多克隆抗体，公司相信这种抗体能够解决严重的未满足医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.236802},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.076928},{"month":3,"riseRate":0.428571,"avgChangeRate":0.034557},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.002953},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.10596},{"month":6,"riseRate":0.5,"avgChangeRate":0.38465},{"month":7,"riseRate":0.571429,"avgChangeRate":0.031244},{"month":8,"riseRate":0.5,"avgChangeRate":-0.026357},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.083718},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.067505},{"month":11,"riseRate":0.571429,"avgChangeRate":0.04362},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.090493}],"exchange":"NASDAQ","name":"Immuron Ltd","nameEN":"Immuron Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuron Ltd,IMRN,Immuron Ltd股票,Immuron Ltd股票老虎,Immuron Ltd股票老虎国际,Immuron Ltd行情,Immuron Ltd股票行情,Immuron Ltd股价,Immuron Ltd股市,Immuron Ltd股票价格,Immuron Ltd股票交易,Immuron Ltd股票购买,Immuron Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}